Get ready for a flood of IPOs
Flood of IPOs land this week

If everything goes as planned, this week will be the busiest for initial public offerings since 2000.

VIDEO ON MSN MONEY

The legendary investor recently visited Japan, sparking rumors that he might see buying opportunities there.

By TheStreet Staff Nov 25, 2011 11:34AM

Image: Japan (© Stockbyte/SuperStock)By Don DionTheStreet


"Our elephant gun has been reloaded, and my trigger finger is itchy."
-- Warren Buffett, 2011 Berkshire Hathaway letter to shareholders

 

With names like Lubrizol and Wesco Financial now decorating the Berkshire Hathaway trophy room, it has clearly been an active year for Warren Buffett in terms of acquisitions. The billionaire has indicated, however, that it is not quite time to hang up the elephant gun.

 

This offshore driller has an aggressive global growth strategy and offers an 8.7% yield.

By TheStockAdvisors Nov 25, 2011 11:23AM
Image: Oil drilling platform (© Scott Gibson/Corbis)By Amy Calistri, The Daily Paycheck

SeaDrill (SDRL) is the second-largest offshore driller, with the second-largest ultra-deepwater fleet.

It operates the world over with 46 rigs, and it's clients include most of the oil and gas exploration heavyweights like Exxon Mobil (XOM), ConocoPhillips (COP), the Norwegian company Statoil (STO) and Argentina's Petrobras (PZE). 
Tags: oilSDRL

The growth outlook unravels as the world's largest economies stumble. And that could be pulling stocks down at a time when investors are hoping for a Santa Claus rally.

By Anthony Mirhaydari Nov 23, 2011 4:10PM

There's so much bad news going around, it's hard to know where to start.

 

Here at home, the deficit-cutting supercommittee failed to deliver, raising the specter of another credit rating downgrade and the expiration of popular short-term stimulus items like payroll tax cuts and unemployment benefits.


The failure also illustrated the fact that the country is increasingly ungovernable at a time when we need swift, thoughtful policy actions.

 

The food company concentrates its business in developed markets that haven't seen a strong recovery.

By Trefis Nov 23, 2011 4:01PM
Image: Groceries (© Tetra Images/Corbis)H.J. Heinz (HNZ) had a challenging second quarter, facing pressure on both top and bottom lines.

Revenue increased just 1% in the quarter, with 80% coming from developed markets that have seen a weak recovery. Sales volume saw a 3% decline, with particularly dismal results from Australia and ongoing weak traffic trends in the U.S.

Compounding the headwinds, gross margin for the quarter worsened by 180 basis points, weighed down by commodity inflation, which outpaced pricing and productivity gains. 

The country is projected to see increasing birth rates through 2016 -- and Mead Johnson Nutrition stands to gain from that rise.

By Jim J. Jubak Nov 23, 2011 3:45PM
Image: China (© Brand X/SuperStock)Next year is the year of the dragon -- the icon of China’s emperors, symbolizing power and wealth.

Families in China see children born in a dragon year as especially fortunate, and these years historically produce a mini baby boom with about 5% more births. Add that to the echo from China’s own baby boom and the loosening of government restrictions on family size, and China is projected to see increasing birth rates that peak around 2016.

That’s led to a stock market boost in shares of companies likely to tap into the baby bump.
 
Tags: MJN

The cost of turkeys has escalated this year, and some stores are deeply discounting the bird to attract shoppers.

By Kim Peterson Nov 23, 2011 3:25PM
Turkeys have not come cheap this year as U.S. farmers have passed steep grain prices on to customers. The traditional Thanksgiving dinner will cost about 13% more this year, according to the American Farm Bureau Federation.

To keep budget-minded customers from getting sticker shock, some grocery chains are deeply discounting the birds. That's created a "turkey war" between stores fighting for every last consumer dollar. 

Passing on Transatlantic and buying into IBM signals a change in investment strategy.

By TheStreet Staff Nov 23, 2011 3:16PM

By Antoine GaraTheStreet


Warren Buffett's Berkshire Hathaway (BRK.B) rarely loses a deal fight, which makes Monday's news that the legendary investor was outbid for reinsurer Transatlantic Holdings (TRH) seem like a strange sight.

 

However, the fact that Berkshire lost out in a hotly contested bid to a competitor a nearly a tenth of its size in Alleghany Corporation (Y) should not be so surprising, given the Omaha, Neb., holding company's move away from its traditional reinsurance and insurance base and its shift to a more diversified portfolio of industrial companies.

 
Tags: ibm

Capital Advisors Growth Fund manager Keith Goddard works to limit losses while maintaining potential for aggressive growth.

By TheStreet Staff Nov 23, 2011 3:10PM

the streetBy Stan Luxenberg

 

All too often, large growth funds have followed a volatile pattern. During bull markets, the growth funds soared as investors bid up prices of fast-moving technology and consumer stocks. Then the rally ended and growth stocks crashed hard as overvalued shares sank.

 

Because of the regular collapses, the large growth category has often trailed large value. From 1928 through 2010, large growth stocks returned 8.8% annually, compared to a figure of 11.1% for large value, according to Ibbotson Associates. In recent years, growth stocks have sunk twice -- after the Internet bubble burst in 2000 and when the financial crisis unfolded in 2008. Hurt by the downturns, large growth funds trailed the S&P 500 ($INX) during the past decade, while large value funds outdid the benchmark.

 

The stock has now dropped below its $20-per-share IPO price.

By TheStreet Staff Nov 23, 2011 2:54PM

Updated: 4:35 p.m. ET

 

By Olivia OranTheStreet


Shares of Groupon (GRPN), which soared 40% two weeks ago during the daily deal site's IPO, continued to crater on Wednesday.

 

The stock fell 15.5% to $16.96. The session low was $16.84. Volume continued to be elevated with more than 5 million shares changing hands by midday. Wednesday's decline follows a 15% drop on Tuesday.

 

The health care products maker is spending $325 million on a private company to bolster its presence in the gastrointestinal diseases therapy space.

By Zacks.com Nov 23, 2011 2:27PM

By: Zacks Equity Research

 

Leading health care products maker Covidien (COV) has cut a deal to buy the outstanding shares of Barrx Medical for $325 million, hoping the move will boost its presence in the gastrointestinal diseases therapy space.

 

Barrx Medical makes ablation catheters and other devices for treating gastrointestinal diseases and Barrett’s esophagus syndrome, a pre-cancerous condition of the lining of the esophagus.

 
Tags: JNJ

The farm machinery maker saw quarterly sales rise 20% from a year earlier to $8.6 billion.

By Zacks.com Nov 23, 2011 2:16PM

Image: Combines in field (© Mark Karrass/Corbis/Corbis)Deere & Co. (DE) outperformed in its fourth quarter, riding a wave of strong demand for farm machinery and increased sales of construction equipment.


The equipment maker delivered earnings of $1.62 per share in the quarter ended Oct. 31, comfortably exceeding the Zacks Consensus Estimate of $1.44. Results were 51% ahead of the $1.07 earned in the year-ago quarter.

 
Tags: CATDE

Early indicators show that Black Friday could be a hit for retailers. Will the rest of the holiday season follow suit?

By Jonathan Berr Nov 23, 2011 1:57PM
Image: Woman with shopping bags (© Tanya Constantine/Getty Images)Shoppers are already camped out at stores across the country in hopes of landing the best Black Friday deals.  

Retailers are hoping that their enthusiasm signals a strong performance for Black Friday, the traditional start of the holiday season. The National Retail Federation recently said that more Americans say they plan to shop for Black Friday bargains than last year. Consumer confidence rose in November to its highest level in November to its highest level in five months. 
Tags: BBYTGTWMT

The two drug companies end a rocky 10-year partnership. What's next for Amylin?

By TheStockAdvisors Nov 23, 2011 1:21PM
By John McCamant, The Medical Technology Stock Letter

Amylin (AMLN) made news recently when it was announced that Eli Lilly (LLY) had broken a deal between the companies for two Type 2 diabetes treatments, Byetta and Bydureon. 

Amylin has also settled a marketing lawsuit it filed against Lilly this year alleging anti-competitive activity after Lilly entered into a marketing deal with Boehringer Ingelheim to sell a competing diabetes drug.

The divorce ends a rocky 10-year partnership between the two companies. 
Tags: AMLNLLY

We expect the automaker to rein in development costs after completing work on the Model S and a new plant.

By Trefis Nov 23, 2011 12:37PM
Tesla Motors' (TSLA) revenue jumped substantially in the third quarter due to strong demand for its Roadster model, higher powertrain component sales and increased payments for development work on Toyota's (TM) RAV4 EV.

But Tesla's costs also increased substantially year over year, primarily due to higher research and development expenses. 
Tags: TSLA

While the market's pullback to key support is a caution sign for now, it’s also likely to result in a rally next week -- one critical to the market’s intermediate-term future.

By MoneyShow.com Nov 23, 2011 12:27PM

By Tom Aspray, MoneyShow.com


The heavy selling Monday and additional losses on Tuesday have taken the major averages to the next key areas of support. Additional selling in the S&P futures early Wednesday has taken them below the 50% Fibonacci support levels.


For those not familiar with Fibonacci analysis, if prices break below the 50% support, it implies that prices will then drop to the 61.8% support. A daily close below that level will give confirmation that the trend has changed from up to down. Of course, in declining markets, we watch to see if the 38.2% retracement resistance is overcome, and if it is, we then look at the 50% and 61.8% retracement resistance levels.

 

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

STOCK SCOUTER

StockScouter rates stocks from 1 to 10, with 10 being the best, using a system of advanced mathematics to determine a stock's expected risk and return. Ratings are displayed on a bell curve, meaning there will be fewer ratings of 1 and 10 and far more of 4 through 7.

124
124 rated 1
267
267 rated 2
467
467 rated 3
605
605 rated 4
645
645 rated 5
691
691 rated 6
617
617 rated 7
459
459 rated 8
313
313 rated 9
130
130 rated 10
12345678910

Top Picks

SYMBOLNAMERATING
AAPLAPPLE Inc10
ATVIACTIVISION BLIZZARD Inc10
BIDUBAIDU Inc10
BMYBRISTOL-MYERS SQUIBB CO.10
CELGCELGENE CORP10
More

Trending NOW

What’s this?

RECENT QUOTES

WATCHLIST

Symbol
Last
Change
Shares
Quotes delayed at least 15 min

ABOUT

Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.

Contributors include professional investors and journalists affiliated with MSN Money.

Follow us on Twitter @topstocksmsn.

MARKET UPDATE

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.
Market index data delayed by 15 minutes

[BRIEFING.COM] The stock market ended the Wednesday session on a mixed note with small caps displaying relative strength. The Nasdaq Composite (+0.5%) and Russell 2000 (+0.4%) registered modest gains, while the Dow Jones Industrial Average (-0.2%) and S&P 500 (+0.01%) underperformed.

Despite the mixed finish, the key indices traded higher across the board at the start of the session after the advance reading of second quarter GDP surpassed estimates (4.0% versus Briefing.com ... More


Currencies

NAMELASTCHANGE% CHANGE
There’s a problem getting this information right now. Please try again later.